Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) (Unaudited) - USD ($)	Preferred stock	Common stock	Additional paid-in capital	Accumulated other comprehensive (loss) income	Accumulated deficits	Noncontrolling interests	Total
Balance at Dec. 31, 2020	$ 532	$ 172,883	$ 61,700,634	$ (13,246)	$ (73,020,134)	$ (877,585)	$ (12,036,916)
Balance (in Shares) at Dec. 31, 2020	531,600	172,883,475
Issuance of shares for director’s remuneration		$ 8,333	491,667				500,000
Issuance of shares for director’s remuneration (in Shares)		8,333,335
Common stock issued upon conversion of debt		$ 12,453	91,714				104,167
Common stock issued upon conversion of debt (in Shares)		12,452,413
Fractional shares from reverse split
Fractional shares from reverse split (in Shares)		800
Foreign currency translation adjustment				23,219			23,219
Net loss for the period					(228,902)	(2,324)	(231,226)
Balance at Mar. 31, 2021	$ 532	$ 193,669	62,284,015	9,973	(73,249,036)	(879,909)	(11,640,756)
Balance (in Shares) at Mar. 31, 2021	531,600	193,670,023
Balance at Dec. 31, 2021	$ 3,190	$ 239,278	65,047,662	(15,826)	(76,908,089)	(887,143)	(12,520,928)
Balance (in Shares) at Dec. 31, 2021	3,189,600	239,278,847
Issuance of shares for redemption of $75,000 promissory note		$ 23,810	51,190				75,000
Issuance of shares for redemption of $75,000 promissory note (in Shares)		23,809,524
Foreign currency translation adjustment				9,329			9,329
Net loss for the period					(781.746)	(2,257)	(784,003)
Balance at Mar. 31, 2022	$ 3,190	$ 263,088	$ 65,098,852	$ (6,497)	$ (77,689,835)	$ (889,400)	$ (13,220,602)
Balance (in Shares) at Mar. 31, 2022	3,189,600	263,088,371